121 related articles for article (PubMed ID: 1657743)
1. Screening for cannabinoids in blood using EMIT: concentrations of delta-9-tetrahydrocannabinol in relation to EMIT results.
Gjerde H
Forensic Sci Int; 1991; 50(1):121-4. PubMed ID: 1657743
[TBL] [Abstract][Full Text] [Related]
2. Blood cannabinoids. II. Models for the prediction of time of marijuana exposure from plasma concentrations of delta 9-tetrahydrocannabinol (THC) and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (THCCOOH).
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):283-90. PubMed ID: 1338216
[TBL] [Abstract][Full Text] [Related]
3. Urinary excretion half-life of delta 1-tetrahydrocannabinol-7-oic acid in heavy marijuana users after smoking.
Johansson E; Halldin MM
J Anal Toxicol; 1989; 13(4):218-23. PubMed ID: 2550702
[TBL] [Abstract][Full Text] [Related]
4. Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
Kraemer M; Madea B; Hess C
Drug Test Anal; 2019 Oct; 11(10):1498-1506. PubMed ID: 31407526
[TBL] [Abstract][Full Text] [Related]
5. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.
Huestis MA; Henningfield JE; Cone EJ
J Anal Toxicol; 1992; 16(5):276-82. PubMed ID: 1338215
[TBL] [Abstract][Full Text] [Related]
6. Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
Moody DE; Monti KM; Crouch DJ
J Anal Toxicol; 1992; 16(5):302-6. PubMed ID: 1338218
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
[TBL] [Abstract][Full Text] [Related]
8. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke.
Cone EJ; Johnson RE
Clin Pharmacol Ther; 1986 Sep; 40(3):247-56. PubMed ID: 3017628
[TBL] [Abstract][Full Text] [Related]
9. Detection of cannabinoids in blood using EMIT.
Peel HW; Perrigo BJ
J Anal Toxicol; 1981; 5(4):165-7. PubMed ID: 6268898
[TBL] [Abstract][Full Text] [Related]
10. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol.
Hartman RL; Brown TL; Milavetz G; Spurgin A; Gorelick DA; Gaffney G; Huestis MA
Clin Chem; 2015 Jun; 61(6):850-69. PubMed ID: 26019183
[TBL] [Abstract][Full Text] [Related]
11. GC/MS and EMIT analyses for delta 9-tetrahydrocannabinol metabolites in plasma and urine of human subjects.
McBurney LJ; Bobbie BA; Sepp LA
J Anal Toxicol; 1986; 10(2):56-64. PubMed ID: 3009969
[TBL] [Abstract][Full Text] [Related]
12. [Serum cannabinoid levels 24 to 48 hours after cannabis smoking].
Skopp G; Richter B; Pötsch L
Arch Kriminol; 2003; 212(3-4):83-95. PubMed ID: 14639811
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity and specificity of serum delta 9-tetrahydrocannabinol and 11-nor-9-carboxy-delta 9-tetrahydrocannabinol by radioimmunoassay in identifying habitual daily smokers of marijuana.
Gong H; Tashkin DP; Valentine JL; Simmons MS; Clark VA; Coulson AH
J Psychoactive Drugs; 1988; 20(1):103-6. PubMed ID: 2839653
[No Abstract] [Full Text] [Related]
14. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
[TBL] [Abstract][Full Text] [Related]
15. Human urinary excretion profile after smoking and oral administration of [14C]delta 1-tetrahydrocannabinol.
Johansson E; Gillespie HK; Halldin MM
J Anal Toxicol; 1990; 14(3):176-80. PubMed ID: 2165199
[TBL] [Abstract][Full Text] [Related]
16. Driving Under the Influence of Marijuana Versus Driving and Dying Under the Influence of Marijuana: A Comparison of Blood Concentrations of Δ9-Tetrahydrocannabinol, 11-Hydroxy-Δ9-Tetrahydrocannabinol, 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol and Other Cannabinoids in Arrested Drivers Versus Deceased Drivers.
Lemos NP; San Nicolas AC; Volk JA; Ingle EA; Williams CM
J Anal Toxicol; 2015 Oct; 39(8):588-601. PubMed ID: 26378132
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the subjective effects of Delta(9)-tetrahydrocannabinol and marijuana in humans.
Wachtel SR; ElSohly MA; Ross SA; Ambre J; de Wit H
Psychopharmacology (Berl); 2002 Jun; 161(4):331-9. PubMed ID: 12073159
[TBL] [Abstract][Full Text] [Related]
18. Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ
Newmeyer MN; Swortwood MJ; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
Clin Chem; 2017 Mar; 63(3):647-662. PubMed ID: 28188235
[TBL] [Abstract][Full Text] [Related]
19. Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.
Johansson E; Halldin MM; Agurell S; Hollister LE; Gillespie HK
Eur J Clin Pharmacol; 1989; 37(3):273-7. PubMed ID: 2558889
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid concentrations detected in fatal road traffic collision victims compared with a population of other postmortem cases.
Andrews R; Murphy KG; Nahar L; Paterson S
Clin Chem; 2015 Oct; 61(10):1256-64. PubMed ID: 26240297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
